NYSE · Drug Manufacturers - General

PFE (PFE) Stock

$26.74 +2.06% NYSE: PFE Healthcare

Valuation

MetricValue
Price$26.74
Market Cap$152.40B
P/E Ratio19.60
P/B Ratio1.69
P/S Ratio2.34
EPS (TTM)$1.36
52-Week High$28.75
52-Week Low$21.87
Dividend Yield6.61%

Financials & Margins

MetricValue
ROE8.31%
ROA5.69%
ROCE17.79%
Gross Margin24.67%
Operating Margin24.67%
Net Margin11.83%
Debt/Equity0.72
Current Ratio1.16

Annual Financials (USD)

Metric20212022202320242025
Revenue$81.3B$100.3B$59.6B$63.6B$62.6B
Operating Profit$20.8B$37.5B$5.3B$16.5B$15.4B
Net Profit$22.1B$31.4B$2.1B$8.0B$7.8B
EPS$3.88$5.47$0.37$1.41$1.36
Op Margin25.6%37.4%8.9%25.9%24.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$181.5B$197.2B$226.5B$213.4B$208.2B
Total Liabilities$104.0B$101.3B$137.2B$124.9B$121.4B
Cash$1.9B$416.0M$2.9B$1.0B$1.1B
Borrowings$37.0B$34.9B$70.8B$67.0B$67.4B

Latest News

MetroLoft Leads $104M Office-to-Residential Bet in FiDi CRE Daily · Jul 16, 2026 Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price 24/7 Wall St. · Jul 15, 2026 Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King 24/7 Wall St. · Jul 15, 2026 Pfizer (PFE) Announces FDA Approval of PADCEV plus Keytruda in MIBC Insider Monkey · Jul 15, 2026 AM Best Affirms Credit Ratings of Blue Whale Re Ltd. Business Wire · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$32.6B$29.3B$8.7B$12.7B$11.7B
Investing Cash Flow$-25.3B$-19.0B$-36.2B$-257.0M$-4.0B
Financing Cash Flow$16.0M$-2.3B$-632.0M$-469.0M$-459.0M
Net Cash Flow$158.0M$-1.5B$2.4B$-1.8B$99.0M
Free Cash Flow$29.9B$26.0B$4.8B$9.8B$9.1B

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA10.54
FCF Yield6.39%
Quick Ratio0.94
Interest Coverage5.78
Return 1Y7.03%
Return 3Y-16.63%
Return 5Y-24.98%

Ownership

Insiders Held0.10%
Institutions Held69.52%
Institutions Float Held69.59%
Institutional HolderSharesReport Date
Blackrock Inc.498,257,5502026-03-31
Vanguard Capital Management LLC369,430,0122026-03-31
State Street Corporation301,589,8652026-03-31
Geode Capital Management, LLC133,561,7422026-03-31
Vanguard Portfolio Management LLC116,734,6952026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMGNAmgen Inc. $387.64 -1.39% 23.42 $209.21B 2.82%
BMYBristol-Myers Squibb Company $63.10 -0.79% 15.73 $128.85B 4.47%
BSXBoston Scientific Corporation $46.04 -0.04% 22.56 $68.43B 0.00%
DHRDanaher Corporation $196.55 -1.26% 33.17 $138.17B 0.75%
GILDGilead Sciences, Inc. $132.73 -1.18% 17.57 $164.79B 2.46%

About PFE

PFE is led by CEO Albert Bourla, employs 81,000 people, headquartered in New York City, US, publicly traded since 1972.

PFE stock trades at $26.74 with a market capitalization of $152.40B. The stock is valued at a price-to-earnings (P/E) ratio of 19.60, price-to-book of 1.69, price-to-sales of 2.34. Over the past 52 weeks the stock has ranged between $21.87 and $28.75, and currently trades 7.0% below its 52-week high. It pays a dividend yielding 6.61%.

On profitability, PFE generates a return on equity (ROE) of 8.31%, return on capital employed of 17.79%, an operating margin of 24.67%, a net profit margin of 11.83%.

In its most recent fiscal year, PFE reported annual revenue of $62.6B, net profit of $7.8B, revenue has compounded at 8.5% a year over the last five years, profit at -3.2% a year.

The balance sheet shows a debt-to-equity ratio of 0.72, a current ratio of 1.16, total assets of $208.2B, $1.1B in cash and equivalents.

PFE has a beta of 0.29 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% DHR Medical - Diagnostics & Research $196.55 -1.26%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides